Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk

Breast Cancer Research and Treatment

Volumn 125, Issue 2, 2011, Pages 563-569

  Justenhoven, Christina ^a,b   Schaeffeler, Elke ^a,b   Winter, Stefan ^a,b   Baisch, Christian ^c   Hamann, Ute ^d   Harth, Volker ^e   Rabstein, Sylvia ^e   Spickenheuer, Anne ^e   Pesch, Beate ^e   Brüning, Thomas ^e   Ko, Yon Dschun ^c   Schwab, Matthias ^a,b,f   Brauch, Hiltrud ^a,b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Johanniter Krankenhaus   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Breast cancer risk; OATP; Polymorphisms; PXR; SLCO

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ORAL CONTRACEPTIVE AGENT; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; SLCO1B3 PROTEIN; SLCO2B1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; ORAL CONTRACEPTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SMOKING; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, STEROID; RISK;

EID: 78650989996     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1046-1     Document Type: Article

References (29)

1. T Key P Appleby I Barnes G Reeves 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606 616 1:CAS:528:DC%2BD38Xjs1eit7w%3D 11959894
2. BT Zhu AH Conney 1998 Functional role of estrogen metabolism in target cells: review and perspectives Carcinogenesis 19 1 27 10.1093/carcin/19.1.1 9472688 (Pubitemid 28376821)
3. T Nozawa M Suzuki H Yabuuchi M Irokawa A Tsuji I Tamai 2005 Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells Pharm Res 22 1634 1641 1:CAS:528:DC%2BD2MXhtVent7nF 10.1007/s11095-005-7096-0 16180120 (Pubitemid 41355902)
4. T Nozawa M Suzuki K Takahashi H Yabuuchi T Maeda A Tsuji I Tamai 2004 Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells J Pharmacol Exp Ther 311 1032 1037 1:CAS:528:DC%2BD2cXhtVKmtL3J 10.1124/jpet.104.071522 15328376 (Pubitemid 39612708)
5. HE Meyer zu Schwabedissen RG Tirona CS Yip RH Ho RB Kim 2008 Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer Cancer Res 68 9338 9347 1:CAS:528:DC%2BD1cXhtlOmt7vP 10.1158/0008-5472.CAN-08-0265 19010908
6. Y Miki T Suzuki K Kitada N Yabuki R Shibuya T Moriya T Ishida N Ohuchi B Blumberg H Sasano 2006 Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma Cancer Res 66 535 542 1:CAS:528:DC%2BD28XhsFWksQ%3D%3D 10.1158/0008-5472.CAN-05-1070 16397270 (Pubitemid 43168338)
7. B Hagenbuch PJ Meier 2004 Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch 447 653 665 1:CAS:528:DC%2BD2cXhtVygt74%3D 10.1007/s00424-003-1168-y 14579113 (Pubitemid 38241451)
8. B Hagenbuch C Gui 2008 Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38 778 801 1:CAS:528:DC%2BD1cXpt1Snurk%3D 10.1080/00498250801986951 18668430
9. MA Hediger MF Romero JB Peng A Rolfs H Takanaga EA Bruford 2004 The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins: introduction Pflugers Arch 447 465 468 1:CAS:528:DC%2BD2cXhtVygt70%3D 10.1007/s00424-003-1192-y 14624363 (Pubitemid 38241432)
10. AT Nies M Schwab D Keppler 2008 Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs Expert Opin Drug Metab Toxicol 4 545 568 1:CAS:528:DC%2BD1cXmtVWrtrg%3D 10.1517/17425255.4.5.545 18484914 (Pubitemid 351890738)
11. A Iida S Saito A Sekine C Mishima K Kondo Y Kitamura S Harigae S Osawa Y Nakamura 2001 Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptides, and three NADH:ubiquinone oxidoreductase flavoproteins J Hum Genet 46 668 683 1:CAS:528:DC%2BD3MXoslWhurY%3D 10.1007/s100380170019 11721887 (Pubitemid 33134745)
12. A Seithel H Glaeser MF Fromm J Konig 2008 The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members Expert Opin Drug Metab Toxicol 4 51 64 1:CAS:528:DC%2BD1cXitlGltr4%3D 10.1517/17425255.4.1.51 18370858 (Pubitemid 351234100)
13. E Hustert A Zibat E Presecan-Siedel R Eiselt R Mueller C Fuss I Brehm U Brinkmann M Eichelbaum L Wojnowski O Burk 2001 Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4 Drug Metab Dispos 29 1454 1459 1:CAS:528:DC%2BD3MXnsl2rsrY%3D 11602521
14. J Zhang P Kuehl ED Green JW Touchman PB Watkins A Daly SD Hall P Maurel M Relling C Brimer K Yasuda SA Wrighton M Hancock RB Kim S Strom K Thummel CG Russell JR Hudson Jr EG Schuetz MS Boguski 2001 The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants Pharmacogenetics 11 555 572 1:CAS:528:DC%2BD3MXotFWlt70%3D 10.1097/00008571-200110000-00003 11668216 (Pubitemid 32953582)
15. M Iwai H Suzuki I Ieiri K Otsubo Y Sugiyama 2004 Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C) Pharmacogenetics 14 749 757 1:CAS:528:DC%2BD2cXhtVais7%2FE 10.1097/00008571-200411000-00006 15564882 (Pubitemid 39552790)
16. T Nozawa H Minami S Sugiura A Tsuji I Tamai 2005 Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms Drug Metab Dispos 33 434 439 1:CAS:528:DC%2BD2MXisFSgtrk%3D 10.1124/dmd.104.001909 15608127 (Pubitemid 40279945)
17. RG Tirona BF Leake G Merino RB Kim 2001 Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans J Biol Chem 276 35669 35675 1:CAS:528:DC%2BD3MXntFahsb4%3D 10.1074/jbc.M103792200 11477075
18. E Link S Parish J Armitage L Bowman S Heath F Matsuda I Gut M Lathrop R Collins 2008 SLCO1B1 variants and statin-induced myopathy-a genomewide study N Engl J Med 359 789 799 1:CAS:528:DC%2BD1cXhtVShtbnF 10.1056/NEJMoa0801936 18650507
19. M Niemi 2007 Role of OATP transporters in the disposition of drugs Pharmacogenomics 8 787 802 1:CAS:528:DC%2BD2sXnvVers7k%3D 10.2217/14622416.8.7. 787 18240907 (Pubitemid 47288978)
20. You G, Morris ME (eds) (2007) Drug transporters. Wiley, Hoboken
21. RM Franke LA Scherkenbach A Sparreboom 2009 Pharmacogenetics of the organic anion transporting polypeptide 1A2 Pharmacogenomics 10 339 344 1:CAS:528:DC%2BD1MXjtlOnsbc%3D 10.2217/14622416.10.3.339 19290786
22. A Kalliokoski M Niemi 2009 Impact of OATP transporters on pharmacokinetics Br J Pharmacol 158 693 705 1:CAS:528:DC%2BD1MXhsVSks7rE 10.1111/j.1476-5381.2009.00430.x 19785645
23. HE Meyer zu Schwabedissen RB Kim 2009 Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms Mol Pharm 6 1644 1661 1:CAS:528: DC%2BD1MXotlOmur0%3D 10.1021/mp9000298 19558188
24. S Ahmed G Thomas M Ghoussaini CS Healey MK Humphreys R Platte J Morrison M Maranian KA Pooley R Luben D Eccles DG Evans O Fletcher N Johnson I Dos Santos Silva J Peto MR Stratton N Rahman K Jacobs R Prentice GL Anderson A Rajkovic JD Curb RG Ziegler CD Berg SS Buys CA McCarty HS Feigelson EE Calle MJ Thun WR Diver S Bojesen BG Nordestgaard H Flyger T Dork P Schurmann P Hillemanns JH Karstens NV Bogdanova NN Antonenkova IV Zalutsky M Bermisheva S Fedorova E Khusnutdinova D Kang KY Yoo DY Noh SH Ahn P Devilee CJ van Asperen RA Tollenaar C Seynaeve M Garcia-Closas J Lissowska L Brinton B Peplonska H Nevanlinna T Heikkinen K Aittomaki C Blomqvist JL Hopper MC Southey L Smith AB Spurdle MK Schmidt A Broeks RR van Hien S Cornelissen RL Milne G Ribas A Gonzalez-Neira J Benitez RK Schmutzler B Burwinkel CR Bartram A Meindl H Brauch C Justenhoven U Hamann J Chang-Claude R Hein S Wang-Gohrke A Lindblom S Margolin A Mannermaa VM Kosma V Kataja JE Olson X Wang Z Fredericksen GG Giles G Severi L Baglietto DR English SE Hankinson DG Cox P Kraft LJ Vatten K Hveem M Kumle A Sigurdson M Doody P Bhatti BH Alexander MJ Hooning AM van den Ouweland RA Oldenburg M Schutte P Hall K Czene J Liu Y Li A Cox G Elliott I Brock MW Reed CY Shen JC Yu GC Hsu ST Chen H Anton-Culver A Ziogas IL Andrulis JA Knight J Beesley EL Goode F Couch G Chenevix-Trench RN Hoover BA Ponder DJ Hunter PD Pharoah AM Dunning SJ Chanock DF Easton 2009 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 Nat Genet 41 585 590 1:CAS:528:DC%2BD1MXjsl2gu7c%3D 10.1038/ng.354 19330027
25. C Justenhoven CB Pierl S Haas HP Fischer C Baisch U Hamann V Harth B Pesch T Bruning C Vollmert T Illig J Dippon YD Ko H Brauch 2008 The CYP1B1-1358-GG genotype is associated with estrogen receptor-negative breast cancer Breast Cancer Res Treat 111 171 177 1:CAS:528:DC%2BD1cXos1Wntrc%3D 10.1007/s10549-007-9762-x 17922187 (Pubitemid 352009231)
26. B Pesch Y Ko H Brauch U Hamann V Harth S Rabstein C Pierl HP Fischer C Baisch C Justenhoven U Ranft T Bruning 2005 Factors modifying the association between hormone-replacement therapy and breast cancer risk Eur J Epidemiol 20 699 711 10.1007/s10654-005-0032-0 16151884 (Pubitemid 41266867)
27. C Justenhoven U Hamann B Pesch V Harth S Rabstein C Baisch C Vollmert T Illig YD Ko T Bruning H Brauch 2004 ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population Cancer Epidemiol Biomarkers Prev 13 2059 2064 1:CAS:528:DC%2BD2cXhtVOjsLvK 15598761
28. E Schaeffeler UM Zanger M Eichelbaum S Asante-Poku JG Shin M Schwab 2008 Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALDI-TOF mass spectrometry: reliable genotyping in different ethnic groups Clin Chem 54 1637 1647 1:CAS:528:DC%2BD1cXht1CiurfM 10.1373/clinchem.2008.103457 18687736
29. JC Barrett B Fry J Maller MJ Daly 2005 Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263 265 1:CAS:528:DC%2BD2MXkt1WitQ%3D%3D 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)